David Jackson

A multifaceted international partnership programme to combat the growing multidrug-resistant tuberculosis (MDR-TB) pandemic is well underway, with a five-year project strategy until the end of 2011 also being developed within South Africa. In 2003, global pharmaceutical giant Lilly launched the Lilly Multidrug-Resistant Tuberculosis Partnership project.

In a world of escalating bad news about crime, poverty, violence and ill health, one project has generated good news, provided hope and turned the tide — the Cipla Medpro Miles for Smiles Foundation. The foundation challenged two extreme athletes to participate in a radical event of their choice to capture the attention of all South Africans.

Since doctors diagnosed the first case of Aids in Botswana in 1985, the disease has spread through the population of 1,7 million at a staggering rate. Today, 25% of adults aged 15 to 49 are infected with HIV. Life expectancy in this small sub-Saharan country has plunged from over 65 to about the age of 52.